Suppr超能文献

胸肩峰动脉和静脉是用于乳房重建的腹壁下动脉穿支(DIEP)皮瓣转移的主要受体血管。

Thoracoacromial artery and vein as main recipient vessels in deep inferior epigastric artery perforator (DIEP) flap transfer for breast reconstruction.

机构信息

Department of Plastic and Reconstructive Surgery, National Center for Global Health and Medicine (NCGM), Tokyo, Japan.

Department of Plastic Surgery, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.

出版信息

J Surg Oncol. 2021 Apr;123(5):1232-1237. doi: 10.1002/jso.26421. Epub 2021 Feb 10.

Abstract

BACKGROUND

The internal mammary artery/vein (IMA/V) are commonly used recipients for free flap breast reconstruction, but requires costal cartilage resection and limits future use of the IMA. This study aimed to evaluate the feasibility of the thoracoacromial artery/vein (TAA/V) as recipients for deep inferior epigastric artery perforator (DIEP) flap breast reconstruction compared with using the IMA/V.

METHODS

Medical charts of patients who underwent free DIEP flap breast reconstruction using the TAA/V or the IMA/V as recipient vessels were reviewed. Patient and vessel characteristics, time for vessel preparation and anastomosis, and postoperative pain were compared between TAA/V and IMA/V groups.

RESULTS

Thirty-four patients were included; 12 in TAA/V group, and 22 in IMA/V group. There was no flap failure in both groups. There were statistically significant differences between TAA/V and IMA/V groups in vessel preparation time (10.9 ± 3.7 min vs. 24.1 ± 6.0 min, p < .001), anastomosis time (31.2 ± 12.1 min vs. 42.1 ± 11.2 min, p = .017), and total dose of acetaminophen (4566.7 ± 1015.6 mg vs. 5436.4 ± 1323.3 mg, p = .041).

CONCLUSIONS

The TAA/V could be safely used as recipient vessels for DIEP flap breast reconstruction with shorter time and less postoperative pain.

摘要

背景

内乳动脉/静脉(IMA/V)通常被用作游离皮瓣乳房重建的受体,但需要切除肋软骨,并限制了 IMA 的未来使用。本研究旨在评估胸廓肩峰动脉/静脉(TAA/V)作为深下腹壁穿支皮瓣(DIEP)乳房重建受体的可行性,与使用 IMA/V 相比。

方法

回顾了使用 TAA/V 或 IMA/V 作为受体血管行游离 DIEP 皮瓣乳房重建的患者的病历。比较 TAA/V 组和 IMA/V 组患者和血管特征、血管准备和吻合时间以及术后疼痛。

结果

共纳入 34 例患者,其中 TAA/V 组 12 例,IMA/V 组 22 例。两组均无皮瓣失败。TAA/V 组和 IMA/V 组在血管准备时间(10.9 ± 3.7 分钟比 24.1 ± 6.0 分钟,p < 0.001)、吻合时间(31.2 ± 12.1 分钟比 42.1 ± 11.2 分钟,p = 0.017)和对乙酰氨基酚总剂量(4566.7 ± 1015.6 毫克比 5436.4 ± 1323.3 毫克,p = 0.041)方面存在统计学差异。

结论

TAA/V 可安全用于 DIEP 皮瓣乳房重建,手术时间更短,术后疼痛更轻。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验